BG Medicine (BGMD) Misses Q1 EPS by 1c

BG Medicine (NASDAQ: BGMD) reported Q1 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $437 thousand versus the consensus estimate of $1.6 million.

For earnings history and earnings-related data on BG Medicine (BGMD) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Home Depot beats estimates, reaffirms fiscal 2026 guidance
• Eltek Ltd (ELTK) Reports Q2 EPS of $0.41